文献速递乳腺癌放疗放疗物理与技术

深度学习预测乳腺癌患者特异性剂量分布

Deep learning method for prediction of patient-specific dose distribution in breast cancer.
PubMed 文献 · Radiat Oncol · 2021-08-17

本研究利用U-net改良剂量预测神经网络,基于50例左侧乳腺癌VMAT计划训练,对10例测试集预测剂量并与RapidPlan比较。深度学习在PTV的D95%和Dmean等指标上误差更小,预测剂量优于RapidPlan生成的VMAT计划。

要点

  • 深度学习可准确预测左侧乳腺癌患者特异性剂量分布。
  • DpNet在PTV的D95%和Dmean上误差小于RapidPlan。
  • 深度学习预测剂量整体优于RapidPlan生成的VMAT计划。

核心结论

  • 深度学习剂量预测方法能准确预测左侧乳腺癌患者特异性剂量,且预测剂量优于RapidPlan生成的VMAT计划。

研究设计与样本

  • 使用50例左侧乳腺癌VMAT计划构建训练与验证数据集,基于U-net改良剂量预测神经网络DpNet,在10例测试集上与RapidPlan比较。

主要发现

  • 临床与深度学习预测模型间PTV的D95%平均绝对误差±标准差为0.02±0.04%,PTV的Dmean为0.01±0.83%。
  • 临床与深度学习预测模型间OARs(body、左乳、心脏、左肺、右肺)的Dmean平均绝对误差±标准差分别为0.16±0.82%、0.52±0.97、-0.88±1.83%、-1.16±2.58%、-0.97±1.73%。
  • 临床与RapidPlan预测模型间PTV的D95%平均绝对误差±标准差为0.02±0.14%,PTV的Dmean为0.87±0.63%。
  • 临床与RapidPlan预测模型间OARs(body、左乳、心脏、左肺、右肺)的Dmean平均绝对误差±标准差分别为-0.29±0.98%、1.30±0.86%、-0.32±1.10%、0.12±2.13%、-1.74±1.79。

临床怎么用

  • 深度学习剂量预测可用于左侧乳腺癌VMAT计划设计,提高剂量预测效率与准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient-specific dose prediction improves the efficiency and quality of radiation treatment planning and reduces the time required to find the optimal plan. In this study, a patient-specific dose prediction model was developed for a left-sided breast clinical case using deep learning, and its performance was compared with that of conventional knowledge-based planning using RapidPlan™. METHODS: Patient-specific dose prediction was performed using a contour image of the planning target volume (PTV) and organs at risk (OARs) with a U-net-based modified dose prediction neural network. A database of 50 volumetric modulated arc therapy (VMAT) plans for left-sided breast cancer patients was utilized to produce training and validation datasets. The dose prediction deep neural network (DpNet) feature weights of the previously learned convolution layers were applied to the test on a cohort of 10 test sets. With the same patient data set, dose prediction was performed for the 10 test sets after training in RapidPlan. The 3D dose distribution, absolute dose difference error, dose-volume histogram, 2D gamma index, and iso-dose dice similarity coefficient were used for quantitative evaluation of the dose prediction. RESULTS: The mean absolute error (MAE) and one standard deviation (SD) between the clinical and deep learning dose prediction models were 0.02 ± 0.04%, 0.01 ± 0.83%, 0.16 ± 0.82%, 0.52 ± 0.97, - 0.88 ± 1.83%, - 1.16 ± 2.58%, and - 0.97 ± 1.73% for D95%, Dmean in the PTV, and the OARs of the body, left breast, heart, left lung, and right lung, respectively, and those measured between the clinical and RapidPlan dose prediction models were 0.02 ± 0.14%, 0.87 ± 0.63%, - 0.29 ± 0.98%, 1.30 ± 0.86%, - 0.32 ± 1.10%, 0.12 ± 2.13%, and - 1.74 ± 1.79, respectively. CONCLUSIONS: In this study, a deep learning method for dose prediction was developed and was demonstrated to accurately predict patient-specific doses for left-sided breast cancer. Using the deep learning framework, the efficiency and accuracy of the dose prediction were compared to those of RapidPlan. The doses predicted by deep learning were superior to the results of the RapidPlan-generated VMAT plan.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Ahn SH, Kim E, Kim C, et al. Deep learning method for prediction of patient-specific dose distribution in breast cancer. Radiat Oncol. 2021. PMID: 34404441. doi:10.1186/s13014-021-01864-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。